Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Mar 17;2(1):135-138.
doi: 10.1016/j.jaccao.2020.01.002. eCollection 2020 Mar.

Infiltrative Lymphoma-Associated Bradycardia and Cardiac Conduction Abnormalities

Affiliations
Review

Infiltrative Lymphoma-Associated Bradycardia and Cardiac Conduction Abnormalities

Pritha Subramanyam et al. JACC CardioOncol. .
No abstract available

Keywords: ABVD, adriamycin, bleomycin, vinblastine, dacarbazine; CMR, cardiac magnetic resonance; ECG, electrocardiography; EF, ejection fraction; FDG, fluorodeoxyglucose; LGE, late gadolinium enhancement; PET-CT, positron emission tomography-computed tomography; R-EPOCH, ritixubimab, etoposide, prednisone, vincristine, cyclophosphamide, doxorubicin; TTE, transthoracic echocardiography; TVP, transvenous pacemaker; bradycardia; cardiac magnetic resonance; cardiac masses; conduction disease; lymphoma; pacemaker.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Summary of Managing Patients With Lymphoma Summary of approach to managing patients with lymphoma at risk for bradycardia and cardiac conduction disease. Timing of permanent pacemaker implantation (asterisk) requires consideration of timing of chemotherapy and its impact on tumor burden and on blood cell counts. (Top) Representative cine cardiac magnetic resonance (CMR) imaging and (Bottom) late gadolinium enhancement (LGE) CMR images of Case 1 and Case 2 patients are also shown to the upper right. Cine-CMR was acquired at different phases of the cardiac cycle. LGE CMR was acquired using long inversion recovery pulse sequence for which inversion times (TI) were tailored to null thrombus (TI 600), whereas contrast enhancement was observed in tissue with vascularity. Neoplastic invasion of the interatrial septum (yellow circles) was present in both patients.

References

    1. Allen D.C., JA, Morton P., Mollan P.A., Morris T.C. Pathology of the heart and conduction system in lymphoma and leukemia. J Clin Pathol. 1987;40:746–750. - PMC - PubMed
    1. Palaskas N.T.K., Gladish G., Agha A.M. Evaluation and management of cardiac tumors. Curr Treat Options Cardiovasc Med. 2018;20:29. - PubMed
    1. McDonnell P.J.M.R., Bulkley B.H. Involvement of the heart by malignant lymphoma: a clinicopathologic study. Cancer. 1982;49:944–951. - PubMed
    1. Chang H.M., Okwuosa T.M., Scarabelli T., Moudgil R., Yeh E.T.H. Cardiovascular complications of cancer therapy: best practices in diagnosis, prevention, and management: part 2. J Am Coll Cardiol. 2017;70:2552–2565. - PMC - PubMed
    1. Chinen K., Izumo T. Cardiac involvement by malignant lymphoma: a clinicopathologic study of 25 autopsy cases based on the WHO classification. Ann Hematol. 2005;84:498–505. - PubMed